Abstract:The emerging antibiotic resistance has been named by the World Health Organization (WHO) as one of the top 10 threats to public health. Notably, methicillin‐resistant Staphylococcus aureus (MRSA) and vancomycin‐resistant Enterococcus faecalis (VREF) are designated as serious threats, whereas Clostridioides difficile (C. difficile) is recognized as one of the most urgent threats to human health and unmet medical need. Among different strategies to combat these bacteria, host‐defense peptide (HDP) – mimicking polymer materials are found to be versatile and promising. However, the vast majority of antibiotic polymer applications were limited to topical application due to their potential systematic toxicity. Herein, we report the design and application of novel biodegradable polymers – the lipidated antimicrobial guanidinylate polycarbonates. These polymers showed potent antimicrobial activity against a panel of Gram‐negative and Gram‐positive bacteria with fast‐killing kinetics and low resistance development tendency. The mechanism of the bacterial killing process was investigated, which suggested that the antimicrobial activity of the polymer was mainly due to bacterial membrane disruption, analogous to that of HDPs. More importantly, the optimal polymer showed excellent antibacterial activity against C. difficile infection (CDI) in vivo via oral administration, which is very unusual as polymer applications are generally limited to injection. In addition, compared with vancomycin, the standard drug for the treatment of CDI but suffers from short protective efficacy and a high relapse rate, the polymer demonstrated a much‐prolonged therapeutic effect and virtually diminished recurrence rate of CDI. The convenient synthesis, easy scale‐up, low cost, as well as biodegradability of this class of polycarbonates, together with their in vitro broad‐spectrum antimicrobial activity and orally in vivo efficacy against CDI, suggest the great potential of lipidated guandinylate polycarbonates as a new class of antibacterial biomaterials to treat CDI and combat emerging antibiotic resistance. This article is protected by copyright. All rights reserved

Peptide-mimicking Poly(2-Oxazoline) Displaying Potent Antibacterial and Antibiofilm Activities Against Multidrug-Resistant Gram-positive Pathogenic Bacteria

Breaking or Following the Membrane-Targeting Mechanism: Exploring the Antibacterial Mechanism of Host Defense Peptide Mimicking Poly(2-Oxazoline)s

Poly(2‐Oxazoline)‐Based Functional Peptide Mimics: Eradicating MRSA Infections and Persisters While Alleviating Antimicrobial Resistance

Host Defense Peptide Mimicking Peptide Polymer Exerting Fast, Broad Spectrum, and Potent Activities Toward Clinically Isolated Multidrug-Resistant Bacteria.

Host-Defense-Peptide-Mimicking β-Peptide Polymer Acting as a Dual-Modal Antibacterial Agent by Interfering Quorum Sensing and Killing Individual Bacteria Simultaneously

Host-Defense-Peptide-Mimicking -Peptide Polymer Acting as a Dual-Modal Antibacterial Agent by Interfering Quorum Sensing and Killing Individual Bacteria Simultaneously

Host defense peptide mimicking poly-β-peptides with fast, potent and broad spectrum antibacterial activities.

Host Defense Peptide-Mimicking Amphiphilic β-Peptide Polymer (Bu:DM) Exhibiting Anti-Biofilm, Immunomodulatory, and in Vivo Anti-Infective Activity

Peptide Polymer Displaying Potent Activity Against Clinically Isolated Multidrug Resistant Pseudomonas Aeruginosa in Vitro and in Vivo

Switching from Membrane Disrupting to Membrane Crossing, an Effective Strategy in Designing Antibacterial Polypeptide

Synthetic Mimics of Antimicrobial Peptides for the Targeted Therapy of Multidrug‐Resistant Bacterial Infection

Cover Feature: Peptide‐Mimicking Poly(2‐oxazoline)s Displaying Potent Antimicrobial Properties (2/2021)

Peptide-mimicking poly(2-oxazoline)s as adjuvants to enhance activities and antibacterial spectrum of polymyxin B

Self-Assembling and Pore-Forming Peptoids as Antimicrobial Biomaterials

Enantiomeric Glycosylated Cationic Block Co-Beta-peptides Eradicate Staphylococcus Aureus Biofilms and Antibiotic-Tolerant Persisters.

Addressing MRSA infection and antibacterial resistance with peptoid polymers

Antibacterial Copolypeptoids with Potent Activity against Drug Resistant Bacteria and Biofilms, Excellent Stability, and Recycling Property

Design and synthesis of broad-spectrum antimicrobial amphiphilic peptidomimetics to combat drug-resistance

Structure-Activity Relationship Study of Antimicrobial Peptide PE2 Delivered Novel Linear Derivatives with Potential of Eradicating Biofilms and Low Incidence of Drug Resistance

Ternary Thermosensitive Hydrogel‐Encapsulated Macrolactam Heneicosapeptide Eliminates Epidermal Multidrug‐Resistant Bi‐Microbial Colonization

Antimicrobial Guanidinylate Polycarbonates Show Oral in Vivo Efficacy Against Clostridioides Difficile